Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ:HROWL) Sees Large Decline in Short Interest

Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ:HROWL) saw a significant drop in short interest in October. As of October 31st, there was short interest totalling 700 shares, a drop of 22.2% from the October 15th total of 900 shares. Based on an average trading volume of 4,000 shares, the short-interest ratio is currently 0.2 days.

Harrow Health, Inc. 8.625% Senior Notes due 2026 Trading Down 0.3 %

Shares of NASDAQ HROWL opened at $25.30 on Friday. The firm’s fifty day moving average is $25.43 and its two-hundred day moving average is $25.25. Harrow Health, Inc. 8.625% Senior Notes due 2026 has a 52-week low of $22.70 and a 52-week high of $25.73.

Harrow Health, Inc. 8.625% Senior Notes due 2026 Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, October 31st. Investors of record on Tuesday, October 15th were given a $0.5391 dividend. The ex-dividend date was Tuesday, October 15th. This represents a $2.16 dividend on an annualized basis and a dividend yield of 8.52%.

About Harrow Health, Inc. 8.625% Senior Notes due 2026

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.